Local hyperthermia treatment of tumors induces CD8+ T cell-mediated resistance against distal and secondary tumors

References

Page 1

	Year	Citations
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments Brain Pathology	2009	4K
Enhancement of Antitumor Immunity by CTLA-4 Blockade Dana R. Leach, Matthew F. Krummel, James P. Allison Science Tumor ImmunologyB7 FamilyAllergyAutoimmune DiseaseCancer Immunosurveillance	1996	3.9K
Development of T <sub>H</sub> 1 CD4 <sup>+</sup> T Cells Through IL-12 Produced by <i>Listeria</i> -Induced Macrophages Chyi‐Song Hsieh, S E Macatonia, Catherine S. Tripp, Science	1993	3.1K
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Glen Dranoff, Elizabeth M. Jaffee, A Lazenby, Proceedings of the National Academy of Sciences VaccinationIrradiated CellsRadiation OncologyTumor ImmunologyCancer Immunosurveillance	1993	2.8K
Thermal dose determination in cancer therapy Stephen A. Sapareto, William C. Dewey International Journal of Radiation OncologyBiologyPhysics Nuclear MedicineEngineeringThermal Dose DeterminationMedicineRadiation Therapy Planning	1984	2.4K
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Matthew F. Krummel, James P. Allison The Journal of Experimental Medicine AllergyAutoimmune DiseaseAdaptive Immune SystemT CellsT-regulatory Cell	1995	2.2K
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. Roberto Manetti, Paola Parronchi, M G Giudizi, The Journal of Experimental Medicine Adaptive Immune SystemT-regulatory CellImmunologyImmunologic MechanismAntigen Processing	1993	1.7K
Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity Eiji Suzuki, Veena Kapoor, Arminder S. Jassar, Clinical Cancer Research	2005	1K
CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative François Ghiringhelli, Nicolas Larmonier, E. Schmitt, European Journal of Immunology T-regulatory CellImmunologyImmune RegulationImmunoeditingRegulatory T Cells	2004	862
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy Keith L. Knutson, Mary L. Disis Cancer Immunology Immunotherapy Tumor ImmunologyCancer ImmunosurveillanceCancer ImmunityT-regulatory CellImmunology	2005	673

Page 1